Advertisement
Screener

Insight Molecular Diagnostics Inc. (IMDX) Equity Method Investment, Ownership Percentage

1.7 / 5 stars · 24/70 Roast Me

Insight Molecular Diagnostics Inc. Equity Method Investment, Ownership Percentage

Insight Molecular Diagnostics Inc. (IMDX) had Equity Method Investment, Ownership Percentage of 5.00% as of 2020-12-31, per its 10-K filed 2021-03-19.

Discontinued › Notes › Investments

us-gaap:EquityMethodInvestmentOwnershipPercentage · last filed 2021-03-19

  • 2020-12-31: Equity Method Investment, Ownership Percentage 5.00%.
  • 2020-09-30: Equity Method Investment, Ownership Percentage 10.00%.
  • 2020-06-30: Equity Method Investment, Ownership Percentage 10.00%.
  • 2020-03-31: Equity Method Investment, Ownership Percentage 10.00%.
Period endEquity Method Investment, Ownership Percentage
2020-12-315.00%
10-K · filed 2021-03-19
2020-09-3010.00%
10-Q · filed 2020-11-12
2020-06-3010.00%
10-Q · filed 2020-07-29
2020-03-3110.00%
10-Q · filed 2020-05-12
2018-09-304.99%
10-Q · filed 2018-11-13
2018-06-304.99%
10-Q · filed 2018-08-14
2016-08-2951.20%
10-K · filed 2018-04-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92